When it comes to promising areas in the treatment of lymphoma and other blood cancers, gene therapy may be at the top of the list. Here’s why.
Pharmacy Best Practices
Are recent pharma price drops just a response to political pressure or will the momentum last? Managed Healthcare Executive asked industry experts, and here’s what they said.
Drug costs are increasing, but so is patient cost sharing. That’s raising serious problems for some patients. Here are seven of the most out-of-reach drugs due to high costs, according to industry watchers.
Prices of more than 20% of generic drugs increased more than 100% between 2010 and 2015.
Reference pricing models are emerging as increasingly popular approaches for lowering drug costs.
We asked several healthcare executives what they are hearing their colleagues talk about the most. Here’s what they said.
Trust in the healthcare sector is dropping, a warning sign to executives. Here’s four ways how to reclaim it.
To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2018.
The International Rare Diseases Research Consortium hopes to develop 200 new drugs for rare diseases by 2020, and it seems as if things are better than on track.
Some of the most amazing things are happening in the delivery of medical care these days. Surgical techniques, new devices, drugs, and diagnostics can treat and cure many medical conditions.